CD86 and cancer: Here we found that LAG3 closely correlated with PD-L1 expression and the PD-1 checkpoint pathway in cancer; and strong correlations were observed between LAG3 and other checkpoint members such as CTLA4, TIGIT, CD28, CD40, CD48, CD27, CD86, ICOS, and IDO1.